CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $191,000 | -9.9% | 12,845 | +2.0% | 0.00% | – |
Q2 2018 | $212,000 | -87.9% | 12,596 | -89.4% | 0.00% | -100.0% |
Q3 2017 | $1,749,000 | +8.9% | 118,600 | +3.0% | 0.00% | 0.0% |
Q2 2017 | $1,606,000 | -18.2% | 115,100 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $1,964,000 | +65.9% | 115,100 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $1,184,000 | +3.0% | 115,100 | +1.2% | 0.00% | 0.0% |
Q3 2016 | $1,149,000 | -9.2% | 113,684 | +0.9% | 0.00% | 0.0% |
Q2 2016 | $1,266,000 | -19.8% | 112,700 | -2.5% | 0.00% | 0.0% |
Q1 2016 | $1,579,000 | -28.0% | 115,600 | 0.0% | 0.00% | -33.3% |
Q4 2015 | $2,193,000 | -40.9% | 115,600 | -41.5% | 0.00% | -50.0% |
Q3 2015 | $3,711,000 | +29.1% | 197,700 | +2.4% | 0.01% | +50.0% |
Q2 2015 | $2,875,000 | +8.6% | 193,100 | +10.4% | 0.00% | 0.0% |
Q1 2015 | $2,648,000 | +13.6% | 174,900 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $2,330,000 | +3.6% | 174,900 | -2.0% | 0.00% | 0.0% |
Q3 2014 | $2,250,000 | -4.8% | 178,400 | -23.8% | 0.00% | 0.0% |
Q2 2014 | $2,363,000 | +61.8% | 234,000 | +115.6% | 0.00% | +33.3% |
Q1 2014 | $1,460,000 | – | 108,515 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |